Morgan Stanley Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN) had its price target decreased by analysts at Morgan Stanley from $45.00 to $39.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target would indicate a potential upside of 20.03% from the company’s previous close.

Several other equities research analysts have also recently issued reports on RYAN. Barclays cut their price target on Ryan Specialty from $41.00 to $39.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $42.00 price objective on shares of Ryan Specialty in a report on Friday, May 1st. Mizuho set a $35.00 target price on Ryan Specialty in a research report on Friday, May 1st. Royal Bank Of Canada assumed coverage on Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 target price on the stock. Finally, Cantor Fitzgerald dropped their price target on Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $47.47.

Ryan Specialty Trading Down 1.6%

Shares of Ryan Specialty stock opened at $32.49 on Thursday. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02. The business has a fifty day simple moving average of $34.23 and a two-hundred day simple moving average of $44.55. Ryan Specialty has a 1 year low of $29.28 and a 1 year high of $72.50. The company has a market capitalization of $8.58 billion, a price-to-earnings ratio of 42.20, a P/E/G ratio of 0.80 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.43 by $0.04. The business had revenue of $795.23 million during the quarter, compared to the consensus estimate of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. Ryan Specialty’s revenue was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.39 EPS. Research analysts forecast that Ryan Specialty will post 2.05 EPS for the current year.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of Ryan Specialty stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the purchase, the director directly owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This represents a 6.33% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 52.03% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of RYAN. Vulcan Value Partners LLC boosted its position in Ryan Specialty by 631.7% in the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock valued at $238,536,000 after buying an additional 3,989,502 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Ryan Specialty by 79.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock worth $389,910,000 after buying an additional 3,353,926 shares in the last quarter. Independent Franchise Partners LLP acquired a new position in shares of Ryan Specialty during the third quarter worth $95,798,000. Adage Capital Partners GP L.L.C. lifted its stake in shares of Ryan Specialty by 1,510.0% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 1,610,000 shares of the company’s stock valued at $83,124,000 after acquiring an additional 1,510,000 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its holdings in shares of Ryan Specialty by 76.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 3,066,011 shares of the company’s stock valued at $172,800,000 after acquiring an additional 1,332,773 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.